BDBM337296 (R)-methyl(7-oxo-6-(1-phenylethyl)-5,6,7,8-tetrahydro-1H-pyrazolo[4,3-g]quinazolin-3-yl)carbamate::US9745307, Example 33
SMILES: COC(=O)NC(=N)c1cc2CN([C@H](C)c3ccccc3)C(=O)Nc2cc1N
InChI Key: InChIKey=SXRRITDVSFXZOM-LLVKDONJSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mitogen-activated protein kinase 1 (Homo sapiens (Human)) | BDBM337296 ((R)-methyl(7-oxo-6-(1-phenylethyl)-5,6,7,8-tetrahy...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete... | US Patent US9745307 (2017) BindingDB Entry DOI: 10.7270/Q28G8NTK | |||||||||||
More data for this Ligand-Target Pair |